SCHEMBL7592652

SCHEMBL7592652

CCCCCOc1cc(C)nc(Nc2ccc(OC)cc2C)c1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.51
KDM4E B2RXH2 2/20 0.51
MAPT P10636 1/20 0.51
PKM P14618 1/20 0.51
CRHR1 P34998 1/20 0.44
SLC2A1 P11166 1/20 0.43
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HSD17B10 Q99714 2/20 0.41
TP53 P04637 1/20 0.40
THRB P10828 1/20 0.40
CYSLTR2 Q9NS75 1/20 0.40
CYSLTR1 Q9Y271 1/20 0.40
SHMT2 P34897 2/20 0.39
HPGD P15428 1/20 0.39
EGFR P00533 1/20 0.39
KDR P35968 1/20 0.39
P2RX7 Q99572 1/20 0.39
ADRA2A P08913 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6798505 0.83 GAA (0.52) GAAKDM4EMAPTPKMCRHR1
SCHEMBL5844564 0.74 MAPT (0.56) GAAKDM4EMAPTPKMCRHR1
SCHEMBL6792213 0.71 CRHR1 (0.44) GAAKDM4EMAPTPKMCRHR1
SCHEMBL6797656 0.69 HPGD (0.47) GAAKDM4EMAPTPKMCRHR1
SCHEMBL6799327 0.69 MEN1 (0.41) GAAKDM4EMAPTPKMCRHR1
SCHEMBL2454085 0.69 PPARG (0.56) HDAC3HDAC1TP53THRBCYSLTR2
SCHEMBL12301283 0.68 ESR1 (0.50) MAPTTHRBCYSLTR2CYSLTR1HPGD
SCHEMBL2448097 0.68 PTPN11 (0.61) KDM4ETP53CYSLTR2CYSLTR1
SCHEMBL3229764 0.68 ALDH1A1 (0.57) KDM4E
SCHEMBL8231851 0.68 THRB (0.50) TP53THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020016328-A1 Corticotropin releasing factor antagonists PFIZER INC. 2002-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020016328-A1 Corticotropin releasing factor antagonists CRH, CRHR2, CRHR1 GAA 2029/4885KDM4E 2820/4885MAPT 2253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.